Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever

Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection

(2011) Georg W. Holzer et al.   VACCINE

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

(2009) R. S. Akondy et al.   JOURNAL OF IMMUNOLOGY

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

(2009) Howard L Kaufman et al.   Journal of Translational Medicine

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

(2009) J. Mayrhofer et al.   JOURNAL OF VIROLOGY

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

(2009) Kathryn C. Meier et al.   PLoS Pathogens

Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer

(2008) Scott S Tykodi et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

(2008) Joseph D. Miller et al.   IMMUNITY

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

(2008) Roger H. Brookes et al.   PLoS One

Adverse event reports following yellow fever vaccination

(2008) Nicole P. Lindsey et al.   VACCINE

Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model

(2008) Milton Maciel et al.   VIROLOGY

Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines

(2007) Linda S. Wyatt et al.   VACCINE